122 related articles for article (PubMed ID: 1744378)
1. Alpha- and beta-adrenoceptor-mediated effects on nerve stimulation-evoked release of neuropeptide Y (NPY)-like immunoreactivity in the pithed guinea pig.
Dahlöf P; Tarizzo VI; Lundberg JM; Dahlöf C
J Auton Nerv Syst; 1991 Sep; 35(3):199-210. PubMed ID: 1744378
[TBL] [Abstract][Full Text] [Related]
2. Alpha 2-adrenoceptor-mediated inhibition of nerve stimulation-evoked release of neuropeptide Y (NPY)-like immunoreactivity in the pithed guinea-pig.
Dahlöf C; Dahlöf P; Lundberg JM
Eur J Pharmacol; 1986 Nov; 131(2-3):279-83. PubMed ID: 3028832
[TBL] [Abstract][Full Text] [Related]
3. Modulatory interactions of neuropeptide Y (NPY) on sympathetic neurotransmission.
Linton-Dahlöf P
Acta Physiol Scand Suppl; 1989; 586():1-85. PubMed ID: 2557726
[TBL] [Abstract][Full Text] [Related]
4. Effect of captopril on plasma levels of neuropeptide Y (NPY)-like immunoreactivity in the pithed guinea pig.
Dahlöf P; Lundberg JM; Dahlöf C
Neuropeptides; 1991 Apr; 18(4):171-80. PubMed ID: 1646971
[TBL] [Abstract][Full Text] [Related]
5. Effects of the neuropeptide Y Y2 receptor antagonist BIIE0246 on sympathetic transmitter release in the pig in vivo.
Malmström RE; Lundberg JN; Weitzberg E
Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):106-11. PubMed ID: 11819028
[TBL] [Abstract][Full Text] [Related]
6. Tetrodotoxin-sensitive release of adrenaline, noradrenaline and neuropeptide Y-like immunoreactivity in the pithed guinea-pig in the absence of electrical preganglionic nerve stimulation.
Dahlöf C; Linton-Dahlöf P; Lundberg JM
J Neurosci Methods; 1994 Jun; 52(2):215-8. PubMed ID: 7967724
[TBL] [Abstract][Full Text] [Related]
7. Pre- and postganglionic stimulation-induced noradrenaline overflow is markedly facilitated by a prejunctional beta 2-adrenoceptor-mediated control mechanism in the pithed rat.
Tarizzo VI; Coppes RP; Dahlöf C; Zaagsma J
Naunyn Schmiedebergs Arch Pharmacol; 1994 Jun; 349(6):570-7. PubMed ID: 7969507
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of neuropeptide Y and noradrenaline mechanisms in sympathetic control of pig spleen.
Lundberg JM; Rudehill A; Sollevi A
Eur J Pharmacol; 1989 Apr; 163(1):103-13. PubMed ID: 2744085
[TBL] [Abstract][Full Text] [Related]
9. Prejunctional regulation of reserpine-resistant sympathetic vasoconstriction and release of neuropeptide Y in the pig.
Modin A; Pernow J; Lundberg JM
J Auton Nerv Syst; 1996 Feb; 57(1-2):13-21. PubMed ID: 8867080
[TBL] [Abstract][Full Text] [Related]
10. Modulation of noradrenaline and neuropeptide Y (NPY) release in the pig kidney in vivo: involvement of alpha 2, NPY and angiotensin II receptors.
Pernow J; Lundberg JM
Naunyn Schmiedebergs Arch Pharmacol; 1989 Oct; 340(4):379-85. PubMed ID: 2555719
[TBL] [Abstract][Full Text] [Related]
11. Evidence for co-transmitter role of neuropeptide Y in the pig spleen.
Lundberg JM; Rudehill A; Sollevi A; Hamberger B
Br J Pharmacol; 1989 Mar; 96(3):675-87. PubMed ID: 2566349
[TBL] [Abstract][Full Text] [Related]
12. Release and vasoconstrictor effects of neuropeptide Y in relation to non-adrenergic sympathetic control of renal blood flow in the pig.
Pernow J; Lundberg JM
Acta Physiol Scand; 1989 Aug; 136(4):507-17. PubMed ID: 2571235
[TBL] [Abstract][Full Text] [Related]
13. Beta-adrenoceptor-mediated inhibition of alpha 1-adrenoceptor-mediated and field stimulation-induced contractile responses in the prostate of the guinea pig.
Haynes JM; Hill SJ
Br J Pharmacol; 1997 Nov; 122(6):1067-74. PubMed ID: 9401771
[TBL] [Abstract][Full Text] [Related]
14. Sympathetic vascular control of the pig nasal mucosa (III): Co-release of noradrenaline and neuropeptide Y.
Lacroix JS; Stjärne P; Anggärd A; Lundberg JM
Acta Physiol Scand; 1989 Jan; 135(1):17-28. PubMed ID: 2911948
[TBL] [Abstract][Full Text] [Related]
15. Effects of antihypertensive drugs on sympathetic vascular control in relation to neuropeptide Y.
Lundberg JM; Pernow J; Franco-Cereceda A; Rudehill A
J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S51-68. PubMed ID: 2455193
[TBL] [Abstract][Full Text] [Related]
16. Possible involvement of neuropeptide Y in sympathetic vascular control of canine skeletal muscle.
Pernow J; Kahan T; Hjemdahl P; Lundberg JM
Acta Physiol Scand; 1988 Jan; 132(1):43-50. PubMed ID: 2906210
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide Y and noradrenaline mechanisms in relation to reserpine induced impairment of sympathetic neurotransmission in the cat spleen.
Lundberg JM; Pernow J; Fried G; Anggärd A
Acta Physiol Scand; 1987 Sep; 131(1):1-10. PubMed ID: 2890260
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of cholinergic and non-adrenergic, non-cholinergic bronchoconstriction in the guinea pig mediated by neuropeptide Y and alpha 2-adrenoceptors and opiate receptors.
Matran R; Martling CR; Lundberg JM
Eur J Pharmacol; 1989 Apr; 163(1):15-23. PubMed ID: 2545461
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide Y (NPY) and the pig heart: release and coronary vasoconstrictor effects.
Rudehill A; Sollevi A; Franco-Cereceda A; Lundberg JM
Peptides; 1986; 7(5):821-6. PubMed ID: 3025824
[TBL] [Abstract][Full Text] [Related]
20. Modulation of noradrenaline release by presynaptic alpha-2 and beta adrenoceptors in rat atria. Effect of pretreatment with clenbuterol.
Kazanietz MG; Enero MA
Naunyn Schmiedebergs Arch Pharmacol; 1989 Sep; 340(3):274-8. PubMed ID: 2554153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
